Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Vaccinex, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 322.1K | 335.5K | +13.4K (+4.2%) |
| Value | $1.81M | $1.14M | −$666.6K (−36.9%) |
New holders (2)
Institutions that held Vaccinex, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 3,402 | $11.6K | 0.00% |
| Barclays PLC | 27 | $92 | 0.00% |
Sold out (1)
Institutions that held Vaccinex, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| AIGH Capital Management LLC | 108,958 | $424.1K |